person
Ewa K. N.
- Country
- Poland
- Department
- n/a
Research Overview
assignment
36
Clinical Trials ·
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of GS-0151 in Patients With Rheumatoid Arthritis: A Clinical Trial
location_city
5
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
723
Sites with multiple studies
Has run more than one trial at 723 of 1109 partner sites.
Specializations
Metabolic and Liver Diseases
The investigator specializes in treating metabolic dysfunction-associated steatohepatitis (MASH) and non-alcoholic steatohepatitis (NASH), with particular focus on patients with liver fibrosis and cirrhosis.
- Liver Fibrosis Management
- Cirrhosis Treatment
- Type 2 Diabetes Care
Autoimmune Conditions
Active in treating various autoimmune disorders, including systemic lupus erythematosus (SLE), Sjögren's syndrome, and psoriatic arthritis.
- Rheumatoid Arthritis Treatment
- Axial Spondyloarthritis Management
- Autoimmune Disease Therapies
Cardiovascular and Renal Medicine
Focuses on atherosclerotic cardiovascular disease prevention and treatment of chronic kidney disease with associated hypertension.
- Cardiovascular Risk Management
- Renal Disease Treatment
- Hypertension Control
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.